TapewireFind a company

person · Reporting owner

SCHULER JACK W

Disclosed activity across 9 companies

Tapewire entity
23810
SEC CIK
0001021412

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Accelerate Diagnostics, IncAXDX · Entity 78156Director · 10% ownerDecember 03, 2024December 03, 2024
Aspira Women's Health Inc.AWHL · Entity 787110% ownerJune 05, 2026June 09, 2026
BIODESIX INCBDSX · Entity 605310% owner · Emeritus DirectorAugust 12, 2026August 13, 2026
BIOLASE, INCBIOL · Entity 1147010% ownerFebruary 11, 2020May 15, 2020
Neos Therapeutics, Inc.NEOS · Entity 14106110% ownerFebruary 17, 2017February 17, 2017
QUIDEL CORP /DE/QDEL · Entity 126712Director · 10% ownerMay 14, 2020May 18, 2020
STERICYCLE INCSRCL · Entity 80873DirectorApril 30, 2018May 02, 2018
YIELD10 BIOSCIENCE, INC.YTEN · Entity 8819510% ownerDecember 20, 2023May 17, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Accelerate Diagnostics, Inc

Report date December 03, 2024 · Filed December 03, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler Living Trust8,310,388 Reported balance After 2024-12-03 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2024-12-03 · Sale · Disposed 200,000 · Balance 8,310,388

F1: Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes.

F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.

Common StockSEC Table I · non-derivativeDirect20,225 Reported balance Holding disclosure · report date 2024-12-03 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 20,225

Common StockSEC Table I · non-derivativeIndirectBy Spouse5,497 Reported balance Holding disclosure · report date 2024-12-03 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 5,497

F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes.

F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.

F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Aspira Women's Health Inc.

Report date June 05, 2026 · Filed June 09, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler Living Trust4,046,051 Reported balance After 2026-06-05 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-06-05 · Purchase · Acquired 222,222 · Balance 4,046,051

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2029-06-05IndirectBy Jack W. Schuler Living Trust300,000 Reported balance After 2026-06-05 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-06-05 · Purchase · Acquired 300,000 · Balance 300,000

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2030-09-17IndirectBy Jack W. Schuler Living Trust833,333 Reported balance Holding disclosure · report date 2026-06-05 · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · Balance 833,333

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.25 · Expires 2030-03-12IndirectBy Jack W. Schuler Living Trust1,801,265 Reported balance Holding disclosure · report date 2026-06-05 · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · Balance 1,801,265

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.13 · Expires 2029-07-26IndirectBy Jack W. Schuler Living Trust28,500 Reported balance Holding disclosure · report date 2026-06-05 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 28,500

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.13 · Expires 2029-01-26IndirectBy Jack W. Schuler Living Trust8,888 Reported balance Holding disclosure · report date 2026-06-05 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 8,888

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

Common StockSEC Table I · non-derivativeDirect6,536 Reported balance Holding disclosure · report date 2026-06-05 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 6,536

Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2027-07-09Direct6,536 Reported balance Holding disclosure · report date 2026-06-05 · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · Balance 6,536

Filing footnotes · ownership attribution and instrument terms

F1: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

BIODESIX INC

Report date August 12, 2026 · Filed August 13, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler Living Trust555,810 Reported balance After 2026-08-12 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2026-08-12 · Purchase · Acquired 15,000 · Balance 555,810

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler 2026 GRAT1,800,000 Reported balance Holding disclosure · report date 2026-08-12 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 1,800,000

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2026 GRAT.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2026 GRAT.

BIOLASE, INC

Report date February 11, 2020 · Filed May 15, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Trust739,820 Reported balance After 2020-02-11 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2020-02-11 · Sale · Disposed 1,307,931 · Balance 739,820

F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

F2: The Common Stock is held directly by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.

Common StockSEC Table I · non-derivativeIndirectBy Spouse20,000 Reported balance Holding disclosure · report date 2020-02-11 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 20,000

F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: These figures reflect a 1-for-5 reverse stock split effected by the Issuer on May 10, 2018.

F2: The Common Stock is held directly by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.

Neos Therapeutics, Inc.

Report date February 17, 2017 · Filed February 17, 2017

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy the Jack W Schuler Living Trust2,338,671 Reported balance Holding disclosure · report date 2017-02-17 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 2,338,671

F1: Jack W. Schuler is the sole trustee of the Jack W Schuler Living Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Jack W. Schuler is the sole trustee of the Jack W Schuler Living Trust. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

QUIDEL CORP /DE/

Report date May 14, 2020 · Filed May 18, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect3,103,249 Reported balance After 2020-05-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2020-05-14 · Exercise / conversion · Acquired 2,100 · Balance 3,103,249

F1: Reflects release of restricted stock units that were previously reported on Form 4.

F2: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares held by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2020-05-14 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-05-14 · Exercise / conversion · Disposed 2,100 · Balance 0

F3: Restricted stock units convert into common stock on a one-for-one basis.

F4: On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on Form 4.

F2: In addition to the shares reported on this Form 4 as directly owned by the Reporting Person, 65,000 shares are held indirectly by the Reporting Person's spouse and 1,105,263 shares are held indirectly by the Schuler Family Foundation. The Reporting Person disclaims all beneficial ownership of the shares held by his spouse and the Schuler Family Foundation, except to the extent of his pecuniary interest, if any.

F3: Restricted stock units convert into common stock on a one-for-one basis.

F4: On May 14, 2019, the reporting person was granted 2,100 restricted stock units vesting on the first anniversary of the grant date.

STERICYCLE INC

Report date April 30, 2018 · Filed May 02, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct2,078 Reported balance After 2018-04-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2018-04-30 · Grant · Acquired 170 · Balance 2,078

F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

YIELD10 BIOSCIENCE, INC.

Report date December 20, 2023 · Filed May 17, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler Living Trust63,789 Reported balance After 2023-12-20 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2023-12-20 · Sale · Disposed 36,000 · Balance 63,789

F1: This late filing is due to an inadvertent administrative error.

F2: On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: This late filing is due to an inadvertent administrative error.

F2: On May 2, 2024 the Issuer effected a 1-for-24 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities beneficially owned following the transaction reported herein has been adjusted and approximated to reflect the Reverse Stock Split.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

SOLENO THERAPEUTICS INC

Report date December 09, 2022 · Filed May 15, 2023

Section 16 reporting ended · disclosed 2023-05-15. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Jack W. Schuler Living Trust36,595 Reported balance After 2022-12-09 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2022-12-09 · Sale · Disposed 10,000 · Balance 36,595

F1: This late filing is due to an inadvertent administrative error.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Filing footnotes · ownership attribution and instrument terms

F1: This late filing is due to an inadvertent administrative error.

F2: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 15, 2023 Filed Oct 10, 2023 20:41 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 PurchaseCommon Stock 765,000 $0.65 $497,250.00
Disclosure

SEC source: 0000908834-23-000120 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 1,637,956

F1 · security: On August 15, 2023, the Issuer completed an offering (the "Offering"), in which the Issuer issued and sold 5,750,000 units (the "Units"), each consisting of (a) one share of Common Stock and (b) one warrant (the "Warrants") to purchase one share of Common Stock. The Units were sold at a per Unit offering price of $0.65. In the Offering, the Jack W. Schuler Living Trust (the "Living Trust") purchased 765,000 Units comprised of 765,000 shares of Common Stock and 765,000 Warrants.

F1 · price: On August 15, 2023, the Issuer completed an offering (the "Offering"), in which the Issuer issued and sold 5,750,000 units (the "Units"), each consisting of (a) one share of Common Stock and (b) one warrant (the "Warrants") to purchase one share of Common Stock. The Units were sold at a per Unit offering price of $0.65. In the Offering, the Jack W. Schuler Living Trust (the "Living Trust") purchased 765,000 Units comprised of 765,000 shares of Common Stock and 765,000 Warrants.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Living Trust, and in such capacity may be deemed to beneficially own the Common Stock and Warrants held by the Living Trust.

Read SEC document
August 03, 2023 Filed Aug 11, 2023 21:34 UTC BIODESIX INC BDSX · Entity 6053 GrantCommon Stock 9,989,506 $1.62 $16,182,999.72
Disclosure

SEC source: 0000905148-23-000681 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 30,579,359

F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
July 24, 2023 Filed Jul 25, 2023 21:39 UTC Aspira Women's Health Inc. AWH · Entity 7871 PurchaseCommon Stock, par value $0.001 181,800 $2.75 $499,950.00
Disclosure

SEC source: 0000908834-23-000088 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 1,883,656

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
June 28, 2023 Filed Jun 29, 2023 17:57 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 GrantEmployee Restricted Stock Units · Derivative 236,842 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-023936 · wk-form4_1688075847.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 236,842

Underlying: Common Stock · 236,842 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024.

F3 · derivative.expiration_date: Not applicable.

Read SEC document
June 09, 2023 Filed Jun 20, 2023 16:10 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 GrantCommon Stock 34,321,163 $1.06 $36,380,432.78
Disclosure

SEC source: 0001104659-23-072885 · tm2319144-1_4seq1.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 57,936,258

F3 · shares: Represents shares issued to the reporting person in connection with the Issuer's repurchase of a secured promissory note previously issued by the Issuer in favor of the reporting person in an aggregate principal amount of $34,933,500, plus accrued interest, and approved by the Issuer's board of directors.

F3 · price: Represents shares issued to the reporting person in connection with the Issuer's repurchase of a secured promissory note previously issued by the Issuer in favor of the reporting person in an aggregate principal amount of $34,933,500, plus accrued interest, and approved by the Issuer's board of directors.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

Read SEC document
June 09, 2023 Filed Jun 20, 2023 16:10 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 GrantCommon Stock 4,878,048 $0.82 $3,999,999.36
Disclosure

SEC source: 0001104659-23-072885 · tm2319144-1_4seq1.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 23,615,095

F1 · shares: Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. (the "Issuer") in connection with an offering by the Issuer exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and approved by the Issuer's board of directors.

F1 · price: Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. (the "Issuer") in connection with an offering by the Issuer exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and approved by the Issuer's board of directors.

F2 · ownership.nature: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 20:29 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 Exercise / conversionEmployee Restricted Stock Units · Derivative 75,949 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-020595 · wk-form4_1685665730.xml · derivative · entry 4

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 75,949 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023.

F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023.

F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 20:29 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 Exercise / conversionCommon Stock 75,949 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-020595 · wk-form4_1685665730.xml · nonDerivative · entry 3

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 31, 2022, the reporting person was granted a total of 75,949 RSUs, which vested in full on May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 1, 2023 19:00 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 14,792 $1.35 $20,006.18
Disclosure

SEC source: 0001140361-23-027746 · form4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,589,853

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 19:00 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 11,849 $1.36 $16,150.19
Disclosure

SEC source: 0001140361-23-027746 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,575,061

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 29, 2023 Filed Jun 1, 2023 18:26 UTC Accelerate Diagnostics, Inc AXDX · Entity 78156 GrantEmployee Restricted Stock Units · Derivative 78,947 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-020564 · wk-form4_1685658387.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,947

Underlying: Common Stock · 78,947 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the "Vesting Date"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served.

F3 · derivative.expiration_date: Not applicable.

Read SEC document
May 25, 2023 Filed May 30, 2023 19:03 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 52,508 $1.36 $71,279.61
Disclosure

SEC source: 0001140361-23-027206 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,563,212

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.295 to $1.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 24, 2023 Filed May 26, 2023 19:00 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 35,308 $1.25 $43,979.64
Disclosure

SEC source: 0001140361-23-026925 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,510,704

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 23, 2023 Filed May 25, 2023 22:21 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 28,873 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-026715 · form4.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,873

Underlying: Common Stock · 28,873 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F4 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.

F4 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

Read SEC document
May 23, 2023 Filed May 25, 2023 19:00 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 56,782 $1.15 $65,066.49
Disclosure

SEC source: 0001140361-23-026580 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,475,396

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.1125 to $1.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 22, 2023 Filed May 24, 2023 19:47 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 29,425 $1.11 $32,529.34
Disclosure

SEC source: 0001140361-23-026395 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,418,614

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.085 to $1.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
May 05, 2023 Filed May 9, 2023 12:11 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 PurchaseCommon Stock Warrants · Derivative 335,570 $2.98 Strike: $2.98 $999,998.60
Disclosure

SEC source: 0001175707-23-000123 · form4.xml · derivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 335,570

Underlying: Common Stock · 335,570 shares

Expires 2028-11-05

F3 · price: In a concurrent private placement effected pursuant to the Purchase Agreement, on May 5, 2023 the Issuer issued to the Investors Warrants to purchase one share of Common Stock at an exercise price of $2.98 per share for each share of Common Stock purchased pursuant to the Purchase Agreement. The reported securities comprise 335,570 Warrants so issued to the Jack W. Schuler Living Trust. The Warrants will be exercisable beginning six months from the date of issuance and will terminate five years from such initial exercisability date.

F3 · derivative.underlying_shares: In a concurrent private placement effected pursuant to the Purchase Agreement, on May 5, 2023 the Issuer issued to the Investors Warrants to purchase one share of Common Stock at an exercise price of $2.98 per share for each share of Common Stock purchased pursuant to the Purchase Agreement. The reported securities comprise 335,570 Warrants so issued to the Jack W. Schuler Living Trust. The Warrants will be exercisable beginning six months from the date of issuance and will terminate five years from such initial exercisability date.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock and Warrants held by the Living Trust.

Read SEC document
May 05, 2023 Filed May 9, 2023 12:11 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 PurchaseCommon Stock 335,570 $2.98 $999,998.60
Disclosure

SEC source: 0001175707-23-000123 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 962,956

F1 · shares: The reported securities comprise 335,570 shares of Common Stock purchased from the Issuer by the Jack W. Schuler Living Trust on May 5, 2023 for $2.98 per share, pursuant to a Securities Purchase Agreement, dated May 3, 2023 (the "Purchase Agreement"), by and among the Issuer and certain investors named therein (the "Investors").

F1 · price: The reported securities comprise 335,570 shares of Common Stock purchased from the Issuer by the Jack W. Schuler Living Trust on May 5, 2023 for $2.98 per share, pursuant to a Securities Purchase Agreement, dated May 3, 2023 (the "Purchase Agreement"), by and among the Issuer and certain investors named therein (the "Investors").

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock and Warrants held by the Living Trust.

Read SEC document
January 31, 2023 Filed Feb 1, 2023 18:03 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 10,000 $2.41 $24,100.00
Disclosure

SEC source: 0001567619-23-001599 · doc1.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,389,189

F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 18:06 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 50,000 $2.51 $125,430.00
Disclosure

SEC source: 0001567619-23-001501 · doc1.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,379,189

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.50 to $2.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:31 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 4,878 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-000671 · form4.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,711

Underlying: Common Stock · 4,878 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.

Read SEC document
January 01, 2023 Filed Jan 4, 2023 23:20 UTC BIODESIX INC BDSX · Entity 6053 GrantRestricted Stock Units · Derivative 62,500 $0.00 $0.00
Disclosure

SEC source: 0001140361-23-000521 · form4.xml · derivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,833

Underlying: Common Stock · 62,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F3 · balance_after: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.

Read SEC document
December 20, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 608 $1.78 $1,082.24
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 12

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 627,386

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 19, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 5,100 $1.76 $8,976.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 11

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 627,994

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:30 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 10,000 $1.70 $17,000.00
Disclosure

SEC source: 0001140361-22-046381 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,339,189

F1 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F1 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 16, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 7,000 $1.82 $12,740.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 10

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 633,094

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 15, 2022 Filed Dec 19, 2022 21:31 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 20,000 $1.65 $32,952.00
Disclosure

SEC source: 0001140361-22-046081 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,329,189

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 15, 2022 Filed Jan 31, 2023 18:00 UTC Amendment BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 10,000 $1.65 $16,476.00
Disclosure

SEC source: 0001567619-23-001499 · doc1.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,319,189

F3 · shares: This amendment is being filed to correct the number of shares reported as purchased by the Jack W. Schuler Living Trust on December 15, 2022, which was inadvertently over-reported as 20,000 shares instead of 10,000 shares in the Form 4 filed by the Reporting Person on December 19, 2022. As such, the total number of shares reported as beneficially owned by the Jack W. Schuler Living Trust in each Form 4 filed between December 19, 2022 and this Form 4 was inadvertently over-reported by 10,000 shares.

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.62 to $1.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3 · balance_after: This amendment is being filed to correct the number of shares reported as purchased by the Jack W. Schuler Living Trust on December 15, 2022, which was inadvertently over-reported as 20,000 shares instead of 10,000 shares in the Form 4 filed by the Reporting Person on December 19, 2022. As such, the total number of shares reported as beneficially owned by the Jack W. Schuler Living Trust in each Form 4 filed between December 19, 2022 and this Form 4 was inadvertently over-reported by 10,000 shares.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 15, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 6,324 $1.88 $11,889.12
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 9

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 640,094

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 14, 2022 Filed Dec 16, 2022 21:30 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 189,675 $1.65 $312,944.78
Disclosure

SEC source: 0001140361-22-045881 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,309,189

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.505 to $1.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 14, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 18,192 $1.89 $34,382.88
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 8

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 646,418

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 13, 2022 Filed Dec 15, 2022 21:30 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 67,402 $1.58 $106,528.86
Disclosure

SEC source: 0001140361-22-045691 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,119,514

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 13, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 7,000 $1.75 $12,250.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 7

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 664,610

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 12, 2022 Filed Dec 14, 2022 21:30 UTC BIODESIX INC BDSX · Entity 6053 PurchaseCommon Stock 100,000 $1.48 $148,380.00
Disclosure

SEC source: 0001140361-22-045539 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 20,052,112

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2 · ownership.direct: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

Read SEC document
December 12, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 4,292 $1.80 $7,725.60
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 6

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 671,610

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 09, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 10,152 $1.88 $19,085.76
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 5

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 675,902

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 09, 2022 Filed May 15, 2023 20:04 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $0.91 $9,100.00
Disclosure

SEC source: 0001175707-23-000147 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 36,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 08, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 5,300 $1.91 $10,123.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 4

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 686,054

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 08, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $0.93 $9,300.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 30

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 46,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 07, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 3,504 $1.91 $6,692.64
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 3

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 691,354

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 07, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $0.96 $9,600.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 29

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 56,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 06, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 7,000 $1.96 $13,720.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 2

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 694,858

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 06, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $0.99 $9,900.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 28

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 66,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 05, 2022 Filed May 9, 2023 12:10 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 7,000 $2.06 $14,420.00
Disclosure

SEC source: 0001175707-23-000122 · form4.xml · nonDerivative · entry 1

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 701,858

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 05, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $0.97 $9,700.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 27

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 76,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 02, 2022 Filed May 9, 2023 12:09 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 3,000 $2.19 $6,570.00
Disclosure

SEC source: 0001175707-23-000121 · form4.xml · nonDerivative · entry 30

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 708,858

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 02, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $1.00 $10,000.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 26

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 86,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 01, 2022 Filed May 9, 2023 12:09 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 3,000 $2.33 $6,990.00
Disclosure

SEC source: 0001175707-23-000121 · form4.xml · nonDerivative · entry 29

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 711,858

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
December 01, 2022 Filed May 15, 2023 20:00 UTC SOLENO THERAPEUTICS INC SLNO · Entity 46432 SaleCommon Stock 10,000 $1.03 $10,300.00
Disclosure

SEC source: 0001175707-23-000146 · form4.xml · nonDerivative · entry 25

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 96,595

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document
November 30, 2022 Filed May 9, 2023 12:09 UTC YIELD10 BIOSCIENCE, INC. YTEN · Entity 88195 SaleCommon Stock 3,000 $2.36 $7,080.00
Disclosure

SEC source: 0001175707-23-000121 · form4.xml · nonDerivative · entry 28

SCHULER JACK W · CIK 0001021412 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Jack W. Schuler Living Trust

Disclosed balance after: 714,858

F1 · date: This late filing is due to an inadvertent administrative error.

F2 · ownership.nature: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the Common Stock held by the Living Trust.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.